TrialJournal of neuro-oncology2010

A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central nervous system tumors.

Amy Rosenfeld et al.PubMed ↗Publisher ↗

No numbers read from the abstract.